Page 38 - COVID-19-Mortality-review-in-Malaysia-and-updates-on-clinical-management-of-COVID-19

They found that there were no significant differences between the groups in
relative risk of:

i) transfer to ICU or death within 7 days,
ii) all causes of mortality within 7 days and

iii) development of ARDS.

Of the 84 patients who received hydroxychloroquine at admission, 8 (9.5%)

developed an electrocardiogram (ECG) change requiring discontinuation of
hydroxychloroquine (7 experienced QT prolongation and 1 developed 1st degree AV
block). 1 of the 8 patients in the no initial hydroxychloroquine group who

subsequently received hydroxychloroquine developed a left bundle branch block.